Trial intelligence / Profile preview

PedPRM and Circadin bioavailability and food-effect crossover study in healthy adults

NL-OMON44644Active, not recruiting

Sponsor
Neurim Pharmaceuticals
Start
Nov 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of melatonin in Insomnia and sleep disorder (4 arms), sponsored by Neurim Pharmaceuticals. Primary endpoints: AUC0-* of PedPRM, Cmax of PedPRM and 2 more. Started Nov 2017; status: active, not recruiting.

02

Drugs

melatonin
03

Conditions

Insomniasleep disorder

Beyond the preview

Go deeper on NL-OMON44644.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON44644.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call